Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, ...

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today the U.S. Food and Drug ...

Shandong Boan Biotechnology Company., Limited. Class H ( ($HK:6955) ) has issued an announcement. Shandong Boan Biotechnology Co., Ltd. announced ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Amgen Inc. is conducting a Phase 4 ...

Question: My doctor recommended vaccines for this fall, how are they covered by Original Medicare? Answer: Vaccines and injections prescribed by our physicians are covered differently depending on ...

BENGALURU, India and BRIDGEWATER, N.J., Sept. 17, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of ...

Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Aukelso is indicated to prevent skeletal-related events in patients with multiple myeloma ...

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Organon & Co. stands eleventh among them. Organon & Co. (NYSE:OGN), a global healthcare company focused on women ...

SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, and Pakistan's The Searle Company Limited (PSX: SEARL, ...